Trials / Conditions / Antiretroviral Therapy

Antiretroviral Therapy

21 registered clinical trials studyying Antiretroviral Therapy.

Status	Trial	Sponsor	Phase
Completed	Enhancing Communication on Relationship Preservation, Safer Conception and PrEP to Promote HIV Testing in Ugan NCT06647797	Children's Mercy Hospital Kansas City	N/A
Completed	First in Human Study of TLC-ART 101 (ACTU 2001) NCT05850728	University of Washington	Phase 1
Completed	Next Generation Ingestible Sensors for Medication Adherence Measurement NCT05592613	Brigham and Women's Hospital	Phase 3
Active Not Recruiting	HIV Transmission in the Era of Scaling up Antiretroviral Therapy in Ethiopia NCT05652400	Lund University	—
Completed	Survey of Procedures and Resources for Initiating Treatment of HIV in Africa-South Africa NCT04170374	Boston University	—
Completed	Survey of Procedures and Resources for Initiating Treatment of HIV in Africa-Zambia NCT04470011	Boston University	—
Unknown	Continuation of Protease-Inhibitor Based Second-Line Therapy vs. Switch to B/F/TAF in Virologically Suppressed NCT04311957	Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic	Phase 4
Completed	Survey of Procedures and Resources for Initiating Treatment of HIV in Africa-Malawi NCT04468399	Boston University	—
Completed	Revised Simplified Algorithm for Treatment Eligibility for HIV (SLATEII) NCT03315013	Boston University	N/A
Completed	Improving Clinic Attendance for Medication Collection Among HIV Positive Individuals in Nepal NCT03367130	Tokyo University	N/A
Completed	Evaluation of a Simplified Strategy for the Long-term Management of HIV Infection (Simpl'HIV) NCT03160105	Calmy Alexandra	Phase 4
Completed	Long Term Outcomes of Therapy in Women Initiated on Lifelong ART Because of Pregnancy in DR Congo NCT03048669	Albert Einstein College of Medicine	N/A
Completed	Smart Linkage-to-HIV Care Via a Smartphone App NCT02756949	World Bank	N/A
Completed	Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa NCT02060162	University of Alabama at Birmingham	—
Completed	Timely Initiation of HIV Antiretroviral Therapy Among Those Who Delay/Decline NCT02086630	New York University	Phase 1
Completed	Mobile Phone Technology for Prevention of Mother-to-Child Transmission of HIV: Acceptability, Effectiveness, a NCT01645865	Elizabeth Glaser Pediatric AIDS Foundation	—
Completed	Raltegravir Switch for Toxicity or Adverse Events NCT00958100	Catholic University of the Sacred Heart	Phase 2
Completed	The Impact of Short Message Services (SMS) on ARV Adherence in Western Kenya NCT01058694	Georgetown University	N/A
Completed	Unboosted Atazanavir as Initial ART Therapy in China NCT01459575	National Center for AIDS/STD Control and Prevention, China CDC	—
Completed	Efavirenz to Nevirapine Switch and Low-Density Lipoprotein (LDL)-Dyslipidemia NCT00405171	University Hospital, Caen	Phase 4
Completed	Effectiveness of Raltegravir-Based Antiretroviral Therapy in HIV-HCV Coinfected Liver Transplant Recipients NCT02995824	Hospital Clinic of Barcelona	—